Submission deadline has passed.
DEADLINE:
The deadline for submission of
Pharmaceutical Pipeline presentation proposals
is February 10, 2012 at 11:59 p.m. CT.
PROPOSAL LIMIT:
An individual cannot be listed as
a presenter on more than 2 submitted
proposals (panels, workshops, methodological
innovations and/or individual/late-breaking
research presentations and pharma pipeline
presentations) per year, and cannot be listed
for more than 4 total roles, i.e., chair,
co-chair, presenter, or discussant. THIS DOES
NOT INCLUDE POSTER PRESENTATIONS. An individual
may be a co-author on any number of submitted
abstracts.
SPECIAL CHARACTERS:
If you use Greek letters, they
will need to be spelled out instead of using the
character.
STEPS FOR SUBMISSION
STEP 1:
Prospective presenters will submit their contact
information and the contact information for
co-author.
STEP 2:
The title, abstract, and submission category are
to be entered or uploaded into the submission
site.
The abstract will provide a
general overview of the proposed presentation
(limited to 3000 characters, including title,
spaces, learning objectives and literature
reference). The abstract is a concise
description of the specific purpose, content,
methodology, results, and importance of the
proposed talk. Please state specific findings
to be presented and the importance of such
findings for advancing the field. NO LITERARY
REFERENCES ARE REQUIRED.
STEP 3:
Upload the presenter’s CV/Brief Biography (Word
or PDF).
STEP 4:
Complete the COI disclosure for
the presenter AND ALL co-authors.
STEP 5:
Proof read the abstract
submission.
STEP 6:
Submit. If you have not completed all required
sections/items you will not be able to submit
your proposal. In the case of missing items, you
will be prompted to enter the missing
information.
For policy questions, please
contact the ASCP Executive Office at
615-649-3085 or
info@ascpp.org.
Presentation Guidelines for
Pharmaceutical Pipeline Session
Each
pharma pipeline report will be a 10 minute
presentation. Please leave adequate time for
audience questions.
Presentations are solely education based. The
use of any advertising, trade names, or
product-group message association is prohibited;
this rule will be strictly enforced.
The
research reporter’s AND ALL co-authors'
disclosures must appear on the first slide of
the presentation. Slides will be reviewed in
the speaker ready room to endure compliance.
Logos
(Company, Institution, University, etc) are not
permitted to appear on meeting materials,
including presentation slides.
Timers
are provided. It is up to the chair of the
session to keep each presenter limited to their
time allotted.
Audiovisual equipment will be available: laptop,
LCD projector, laser pointer, podium, and
microphone.
Rules Regarding Conflict of
Interest
Authors of scientific oral or poster
presentations who have entered into a financial
relationship with sponsoring companies or
organizations about whose products or services
they are reporting must disclose this
information. Disclosures for ALL authors should
be included on the poster.
It is recognized that much scientific research
is supported by organizations that have a
commercial interest in the results of the
research. This policy is not intended to
discourage such support, or restrict the
dissemination of the research. It is the intent
of this policy to require authors of scientific
presentations to disclose the sources of their
support, when those sources have a direct
interest in the research. This is to permit
members of the audience to form their own
judgments about the research with the full
disclosure of the facts.
Submission deadline has passed.
